您的位置: 首页 > 农业专利 > 详情页

Composition for treating hyperlipidemia comprising oxyntomodulin derivative
专利权人:
Hanmi Pharm. Co.; Ltd.
发明人:
Jung, Sung Youb,Kim, Jin-Sun,Jang, Myung Hyun,Lee, Sang Hyun,Choi, In Young,Kwon, Se Chang
申请号:
AU2013293714
公开号:
AU2013293714A1
申请日:
2013.07.25
申请国别(地区):
AU
年份:
2015
代理人:
摘要:
The present invention relates to a composition for preventing or treating hyperlipidemia, fatty liver disease or arteriosclerosis, comprising an oxyntomodulin derivative as an active ingredient. The oxyntomodulin derivative has a high ability to activate GLP-1 receptor and glucagon receptor compared to native oxyntomodulin and has the effects of reducing the blood total cholesterol, low-density cholesterol and triglyceride levels that were increased by high-fat diet, and increasing high-density cholesterol levels and the high-density cholesterol/low-density cholesterol ratio. Thus, the oxyntomodulin derivative can be effectively used for the treatment of hyperlipidemia and related diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充